Monte Rosa announced clinical results from its MRT-6160 Phase 1, single ascending dose / multiple ascending dose study. Details about the study, First-in-human Study of MRT-6160 in Healthy ...

Times may be strange and Fashion Week stressful, but Paula Canovas del Vas admits that she thrives in chaos. On their way into the Spanish embassy on the Avenue George V, where her presentation ...

The Vanguard Australian Shares Index ETF (ASX: VAS) has declined 8% in the past month, as the chart below shows. With that fall, the VAS ETF is back to where it was in August 2024. The decline isn ...